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Introduction 
 Cervical spondylotic myelopathy (CSM), defined as “compression of the spinal cord in 
the cervical area of the spine”, which ranges widely in severity and mechanism. [1] In North 
America, the prevalence (the number of people currently living with cervical spinal myelopathy) 
is estimated at 605 per million. The annual incidence (the rate of cases per person-time) is 
estimated at 4.04 cases/ 100,000 people/ year, which equates to approximately 23,000 new cases 
each year. [2] These metrics do not uniformly affect the entire population with CSM found in 85% 
of the individuals over 60. [3] The most common modes of onset are due to the aging process 
which results in degenerative changes and in advanced cases, compression of the spinal cord. [4]  
 The region of the spine affected can result in instability of gait, loss of fine motor control 
of upper limbs, weakness, and neck pain with reduced range of motion.[5] Patients with CSM 
incur great cost for chronic treatments as well as surgery, with the average patient in 2012 
spending $32,916 per quality-adjusted life year on surgery.[6] Severe cases of CSM can result in 
patients having severe pain, a loss of mobility, and increased social and economic ramifications. 
CSM can result in lower quality of life as demonstrated by consistent Short Form Survey- 36 
(SF-36), specifically in the younger population. [7] Due to the severe social and economic 
consequences, our ability to prognosticate neurological and functional recovery is critical to 
patient counseling and resource distribution. Additionally, proper measurements to assess CSM 
progression could potentially improve outcomes and treatment plans.  
 The two available options clinicians offer patients are primarily surgical and in some 
cases non-surgical treatment. Surgical decompression is the most common procedure used to 
stabilize the spine in severe cases. It has been found that approximately two-thirds improve 
following surgery with 15-30% of cases being unsuccessful.[8] There is some debate as to which 
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approach is optimal for treatment of CSM. In the US, the three most common are anterior 
decompression and fusion, posterior decompression and fusion, and laminoplasty. [9] Each 
technique has its own benefits and drawbacks taking into consideration the number of levels each 
patient has compressed. However, the ultimate goal of these surgeries is the same through 
relieving pressure from the spinal cord and allowing the nerves to no longer be compressed. [10] 
 The current research involving CSM involves studying surgical outcomes and 
determining the most reliable outcome measurements including radiological variables. Previous 
to this study, a thoracic myelopathy study has found intermedullary lesion length (IML) to be a 
factor to predict postoperative recovery.[16] In this paper, I will investigate the relative ability for 
various radiological parameters to serve as measurements that can improve outcomes and 
treatment plans in CSM. Parameters we looked at include age, sex, weight, smoking history, 
diabetes, coronary artery disease, hypertension, COPD, chronic heart failure, symptom duration, 
and previous history in a retrospective analysis presenting to Dr. Farhadi in a consecutive case 
series.  
 The relevant admission magnetic resonance imaging (MRI) study parameters are defined 
on page 7 of this text. Torg- Pavlov, Lateral-Mass Canal, T1 Change, T2 Change, Compression 
levels with only anterior or posterior, Compression levels with both anterior and posterior, and 
Compression levels with both. An important component regarding patient recovery studied was 
the Modified Japanese Orthopedic Association (mJOA). This measurement is an investigator- 
administered tool that can evaluate neurological function in patients with CSM based on an 18 
point scale. It specifically looks at upper extremity (5 points) and lower extremity (7 points) 
motor function, sensation (3 points) and micturition (3 points). A total score of 18 reflects no 
neurological deficits whereas a lower score indicates a greater degree of disability and functional 
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impairment. Severe cases are classified approximately from 0-11, moderate are 12-14, and mold 
are 15-17. [11] One limitation of this system is that is does not address the sensory function in the 
trunk or lower extremities. [12] Another investigator administered tool used to evaluate functional 
status in patients with degenerative cervical myelopathy was the Nurick grade. This tool is a 5 
points scale looking at functional impairment in DCM. Sever cases are classified from 3-5 with 
moderate cases ranging from 1-2 and healthy patients with a score of 0.  
 Non-surgical treatments of CSM are limited and may be treated with cervical 
immobilization, analgesics, anti-inflammatory and physiotherapy.[13] In cases associated with 
cervical radiculopathies, drugs such as tricyclic antidepressants, anticonvulsants or even 
antagonists of drugs N-methyl-D-aspartate receptors as riluzole may be used.[14] The new 
potential treatment of riluzole was found to reduce oxidative damage in animal models and 
improve long term function following decompression surgery. [15] Recent phase 3 clinical trials 
show a potential treatment for non-surgical options. However, no treatment except surgical 
decompression has been proven in humans to promote recovery due to the heterogeneity of the 
condition. 
 Previous studies have shown mJOA to be useful in assessing pre-surgical vs. post- 
surgical analysis. (Figure 2) Similar statistical testing will be employed here to assess the 
potential significance of these admission findings in the context of cervical spondylitic 
myelopathy. The use of various radiological parameters as measures compared to mJOA may 
also help further stratify patients in clinical trials to assess for potential therapeutic benefits.  
Methods 
Research Questions 
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• What is the ability of various admission imaging parameters in predicting neurologic 
recovery for patients with degenerative CSM following surgery? 
• Can these various parameters be used for prognosticating recovery and improve mJOA 
following surgical decompression?  
 
Study Population 
 A total of 368 patient medical records tagged for myelopathy were reviewed. From this 
population, a total of 50 patients fit the inclusion criteria, and were included in this analysis 
(Figure 1). Males and females were equally represented. However, of the sample group that had 
no ΔmJOA, more males were present with 72.2% being represented. The mean age of the cohort 
was 64.33 ± 10.79 for patients with no change in ΔmJOA and 63.53 ± 9.93 for patients with a 
change in ΔmJOA. There was a disproportionately represented of patients over the age of 55 due 
to the nature of myelopathy. BMI ranged significantly with patients with no change in ΔmJOA 
having a mean of 28.07 ± 7.84 and patients with a change in ΔmJOA having a mean of 32.66 ± 
6.20. Smoking status was highly variable with patients with no change in ΔmJOA having 16.7% 
current smokers, 50% former smokers, 33.3% never. Patients with a ΔmJOA had 21.9% current 
smokers, 37.5% former smokers, and 40.6% never. Type II diabetes mellitus was relatively 
similar with patients with no ΔmJOA having a mean of 27.8% and patients with a ΔmJOA 
having a mean of 21.9%. Coronary Artery Disease was present in 16.7% of patients with no 
ΔmJOA and 21.9% of patients with a ΔmJOA. Hypertension was very common with a mean of 
61.1% of patients without a ΔmJOA and 65.6% of patients with a ΔmJOA. COPD/ Pulmonary 
hypertension had a mean of 22.2% of pateitns without a ΔmJOA and 15.6% of patients with a 
ΔmJOA. Additionally, chronic heart failure was present in 5.6% of patients with no ΔmJOA and 
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9.4% of patients with a ΔmJOA. Duration of symptoms had a mean of 21.39 ± 27.27days for 
patients with no ΔmJOA and a mean of 37.13 ± 64.89days for patients with ΔmJOA. Finally, 
history of other neck surgery was also observed with a mean of 16.7% of patients without a 
ΔmJOA and 15.6% of patients with ΔmJOA.  
Study Design 
 Institutional Review Board approval was obtained and followed throughout the duration 
of the study. This study was conducted using a single surgeon retrospective analysis following 
consecutive surgical patients. This study design allows for a good estimate of risk, and a clear 
temporal relationship between surgical decompression and outcomes (neurologic severity and 
mJOA change). This study design also allows investigators to investigate more than one 
outcome. However, retrospective studies are potentially hampered by loss-to-follow up as well as 
potential different modes of data collection across institutions. Data was drawn from the IHIS 
Electronic Medical Record System. 
Data Collection 
 Patients were enrolled in a prospective fashion and the data was collected from 368 
patient medical record numbers (MRNs) associated with myelopathy of lumbar, thoracic, and 
cervical regions from Information Warehouse at The Ohio State University. All patients were 
evaluated at The Ohio State Wexner Medical Center in a consecutive series from 2013-2018. 
The patients were analyzed with regard to the following inclusion and exclusion criteria (figure 
1). 
Inclusion/ Exclusion Criteria 
 Patients with thoracic or lumbar myelopathy were excluded. Patients who had other 
diagnoses than CSM were excluded. Patients with cervical radiculopathy, abysses, infections or 
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trauma were excluded. Patients with less than one year follow up were excluded. Patients that 
had concomitant severe lumbar stenosis requiring surgery were excluded due to confounding 
symptoms resulting from their lumbar diagnosis. The inclusion criteria were as follows: (1) 18 
years of age or older (2) Diagnosis of CSM (3) Underwent cervical surgical fusion 
decompression by Dr. Farhadi (4) Admitted directly to Ohio State University Wexner Medical 
Center, or transferred with full documentation of care; (5) presence of admission MRI; (6) 
availability of one-year follow-up data. The presence of admission imaging was of paramount 
importance, as 12 of the MRI parameters were used to prognosticate outcomes following surgical 
decompression. 
Study Parameters 
• Torg Pavlov was used to evaluate canal stenosis and cord compression. This measure is a 
continuous variable calculated by dividing the sagittal diameter of the spinal canal to the 
sagittal diameter of the corresponding vertebral body. This measurement is useful to 
describe developmental spinal canal stenosis and has been proven to be reliable for 
determining cervical spinal stenosis. Collected at levels C3-C6 of the spine and averaged. 
• Lateral Mass to Canal diameter was also used to evaluate canal stenosis and cord 
compression. This measure is a continuous variable calculated by dividing the overlay of 
facet articulations on lateral cervical radiographs. These facet articulations share a 
roughly similar geographic location as the spinal canal. This measurement is useful to 
detect spinal canal narrowing and stenosis. One limitation of this method are patients 
with congenital spinal stenosis which is a condition in which this method would not 
account for the already narrow spine.  Collected at levels C3-C6 of the spine and 
averaged. 
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• The number of compression levels with anterior and posterior CSF, number of levels with 
only anterior or posterior CSF, and the number of levels with both were used to assess 
cervical compression of the spinal cord on MRI.  
• The T2 and T1 change on cervical MRI was used to evaluate edema, swelling, and 
myelomalacia. A T2 weighted signal appears bright and have hyperintensity on the MRI 
due to the length of time taken to decay. However, this is difficult to differentiate 
between edema and myelomalacia. The length and number of levels with the positive T2 
signal was also measured. In a T1 weighted signal, the presence of a signal evaluates the 
density of tissue and more directly refers to myelomalacia or the irreversible death of 
cells. 
• Cervical Kyphosis was used to evaluate abnormal curvature in the spine or neck. Creating 
a C-like curve in the cervical region of the spine, MRI’s of patients were quantified using 
a binary system, with 0 indicating no kyphosis and 1 indicating kyphosis based on 
appearance of spine. 
• MRI AP (Anteroposterior) Canal Diameter (most severe) was used to evaluate canal 
stenosis and cord compression. This was done by taking a sagittal measurement of the 
cervical spine on an MRI from  
• Spinal Cord-most narrow/severe 
• The Modern Japanese Orthopedic Association (mJOA) score is a validated, investigator-
administered tool used to evaluate functional status in patients with degenerative cervical 
myelopathy (DCM). It specifically looks at upper extremity (5 points) and lower 
extremity (7 points) motor function, sensation (3 points) and micturition (3 points). A 
total score of 18 reflects no neurological deficits whereas a lower score indicates a greater 
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degree of disability and functional impairment. Severe cases are classified approximately 
from 0-11, moderate are 12-14, and mild are 15-17. [11] One limitation of this system is 
that is does not address the sensory function in the trunk or lower extremities (Figure 2). 
• The Nurick grade is a validated, investigator-administered tool also used to evaluate 
functional status in patients with degenerative cervical myelopathy (DCM). It is a 5 
points scale looking at functional impairment in DCM. Severe cases are classified from 
3-5 with moderate cases ranging from 1-2 and healthy patients with a score of 0.  
Statistical Methods 
 The statistical analyses for this study were conducted using SPSS with a reference 
significance value of ≤ 0.05 for univariate analysis and ≤0.15 for multivariate analysis. 
Categorical variables were analyzed with Chi-square tests, univariate and multivariate with help 
of Dr. Farhadi. (Tables 1and 2; Table 3 respectively). These categorical variables are presented 
as the number of subjects and relative frequencies. Continuous variables are presented as the 
mean and standard deviation or median, when appropriate. 
Results 
MRI Findings 
 Cervical spine MRI studies were performed on admission in 50 patients (Table 2). 
Cervical Kyphosis was found to be present in 33.3% of patient who had no significant change in 
ΔmJOA and found in 3.1% of patients who had significant change in ΔmJOA . The number of 
levels without CSF in both the anterior and posterior region had a mean of  1.72 ± 1.13 for 
patients with had no significant change in ΔmJOA and a mean of 0.91 ± 0.78 for patients with a 
significant change in ΔmJOA. The number of levels without CSF in both the anterior OR 
posterior region had a mean of 0.94 ± 0.80 for patients with had no significant change in ΔmJOA 
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and a mean of 1.09 ± 0.86 for patients with a significant change in ΔmJOA. Combining these 
two parameters to create the overall compressed levels led to a mean of 2.67 ± 1.19 for patients 
with had no significant change in ΔmJOA and a mean of 2.00 ± 1.11 for patients with a 
significant change in ΔmJOA. A positive T2 signal was assessed and found to have 83.3% of 
patients which had had no significant change in ΔmJOA and 34.4% of patients with a significant 
change in ΔmJOA. The number of levels of T2 change was found to have a mean of 1.28 ± 1.02 
for patients that had no significant change in ΔmJOA and 0.34 ± 0.48 for patients that had 
significant change in ΔmJOA.  
 Intramedullary Lesion length (IML) was assessed along the sagittal plane of the T2 
signal. The mean rostrocaudal length of IML was found to be 12.57 ± 9.84 mm in patients that 
had no significant change in ΔmJOA and 2.78 ± 4.43 mm in patients that had significant change 
in ΔmJOA. A positive T1 signal change was assessed and found to have 16.7% of patients which 
had had no significant change in ΔmJOA and 6.3% of patients with a significant change in 
ΔmJOA. The most severe MRI Anteroposterior Canal diameter had a mean of 5.18 ± 1.18 mm 
for patients who had no significant change in ΔmJOA and 6.69 ± 1.76 mm for patients who had 
significant change in ΔmJOA. Spinal cord length (most severe) was also taken and found to have 
a mean of 3.86 ± 1.06 mm for patients who had no significant change in ΔmJOA and 4.96 ± 1.11 
mm for patients who had significant change in in ΔmJOA. Torg Pavlov Ratio average of the four 
levels (C3-C6) was found to have a mean of 0.65 ± 0.12 for patients with no significant change 
in ΔmJOA and 0.77 ± 0.14 for patients with significant change in ΔmJOA. Lateral Mass Canal 
Diameter Ratio Average of the four levels (C3-C6) was found to have a mean of 0.69 ± 0.06 for 
patients with no significant change in ΔmJOA and 0.71 ± 0.05 for patients with significant 
change in ΔmJOA.  
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Clinical Variables and Outcomes 
 Clinical variables were analyzed using univariate chi-square testing to assess clinical 
parameters between patients with no significant ΔmJOA and patients with significant ΔmJOA 
(Table 1). Neurological severity was quantified using the number of patients which improved 
mJOA (ΔmJOA) compared to those who remained the same. Follow up time was not 
significantly associated with ΔmJOA (p=0.571). This is important to confirm the clinical 
relevance of the study suggesting the length of time taken to follow up is not a confounding 
variable. Another important variable was that the pre-op mJOA was not significantly associated 
with ΔmJOA (p=0.939). This also confirms that patients had similar pre-mJOA before surgery.  
 Age was not significantly associated with ΔmJOA (p = 0.792). Sex was not significantly 
associated with ΔmJOA (p=0.264) BMI was found to be significantly associated with ΔmJOA 
(p=0.027). Smoking Status was not significantly associated with ΔmJOA (p=0.689). Type 2 
Diabetes Mellitus was not significantly associated with ΔmJOA (p=0.0639). Coronary Artery 
Disease was not significantly associated with ΔmJOA (p=0.730). Hypertension was not 
significantly associated with ΔmJOA. (p=0.750). COPD and pulmonary hypertension were not 
significantly associated with ΔmJOA (p=0.705). Chronic heart failure was not significantly 
associated with ΔmJOA (p≥0.99). Duration of symptoms were not significantly associated with 
ΔmJOA (p=0.435). History of neck symptoms were not significantly associated with ΔmJOA 
(p≥0.99). Pre- op Nurick was significantly associated with ΔmJOA (p=0.014).   
 
MRI Variables and Outcomes 
 MRI variables Cervical Kyphosis, no CSF Ant/Pst, No CSF Ant OR Pst, Compressed 
levels, T2 signal change, #levels with T2 signal change, IML, T1 signal change, MRI AP Canal 
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Diameter (most severe), Spinal Cord-most narrow/ severe, Torg Pavlov average, Lateral Mass 
Canal Dia. Avg were analyzed using univariate chi-square testing to assess radiologic severity 
between patients with no significant ΔmJOA and patients with significant ΔmJOA (Table 2). 
 Cervical Kyphosis was significantly associated with ΔmJOA (p=0.006). Compression of 
both the anterior and posterior side of the spinal cord was significantly associated with ΔmJOA 
(p=0.010). Compression of only the anterior or posterior side of the spinal cord was not 
significant in ΔmJOA (p=0.490). The total number of compressed levels was significant in 
ΔmJOA (p= 0.038). T2 signal change was significantly associated with ΔmJOA (p=0.001). The 
number of levels with a T2 signal change was significantly associated with ΔmJOA (p<0.001). 
IML length was significantly associated with ΔmJOA (p<0.001). T1 signal change was not 
significantly associated with ΔmJOA (p=0.336).  MRI AP Canal Diameter (most severe) was 
significantly associated with ΔmJOA (p=0.003). Spinal Cord-most narrow/severe was 
significantly associated with ΔmJOA (p=0.001). Torg Pavlov average was significantly 
associated with ΔmJOA (p=0.007). Lateral mass canal dia. Avg was not significantly associated 
with ΔmJOA (p=0.385).  
 A multivariate analysis was conducted to find prognosticating risk factors associated with 
ΔmJOA. The three factors found to be significant were BMI, Cervical Kyphosis, and IML.  
By reducing codependence and covariance to determine what remains statistically significant, 
this analysis found new p-values compared to previously. BMI was found to be significantly 
associated with ΔmJOA (p=0.048). Cervical Kyphosis was found to be significantly associated 
with ΔmJOA (p=0.091). Finally, IML was found to be significantly associated with ΔmJOA 
(p=0.006). 
Discussion 
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 All current intervention for cervical spondylotic myelopathy is surgical decompression 
and aimed at improving recovery following surgery. Several factors contribute to the lack of 
prognostic factors in human CSM patients. The preoperative mJOA score is one factor 
contributing to the lack due to a lack of proper prediction of outcomes (as found in Table 2). The 
scale has too much inter and intra variability resulting in an improper stratification. The 
heterogeneity of the condition confounds the analysis of potential prognostic factors and novel 
prognosticating indexes. Additionally, because of the nature of cervical spondylotic myelopathy, 
other diagnoses can confound symptoms and neurologic evaluation in patients. With the cervical 
region being the most superior region, it also affects many other areas of the spinal cord. If 
stenosis is severe enough, patients can lose feeling below the arm. With the greater percentage of 
patients being in the age group over 60, age is a confounding variable which may further cloud 
the neurologic evaluation. Improved prognostication would help clinicians better counsel 
patients with regard to their expected recovery. This counseling is especially important in CSM 
because of the lifelong associated social and economic burdens and the increased aging 
population. In the realm of clinical research, improved prognostication would also allow for 
more rational clinical trial design with improved patient stratification. Researchers could then 
better assess the efficacy of surgical interventions in CSM patients.  
 Cervical Spondylotic Myelopathy represent a particularly heterogenous cohort, and 
stenosis can be variable. Since the rate and degree of neurologic deterioration is variable and 
optimal management strategies are complex, it is difficult to quantify similar damage to the 
spinal cords. The cause of CSM is relatively unknown with changes in the cervical spine 
producing narrowing of the canal itself. This can lead to the thickening of ligaments and bone 
spur (osteophyte) formation causing compression. The chronic compression of the spinal cord 
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and nerve roots leads to impaired blood flow and neurological deficits. The aforementioned 
variables help to explain why distinct anatomical regions within the cervical spine show 
differential rates of neurologic recovery.  
 This study has allowed for novel insight into potential prognosticating factors to assess 
outcomes following surgical intervention. We identified associations between clinical factors 
such as BMI and radiologic factors such as Cervical Kyphosis and IML with respect to patients 
with no significant ΔmJOA and patients with significant ΔmJOA (Table 3). The potential role of 
obesity in neural recovery is not well understood. A larger sample of cervical spondylotic 
myelopathy patients is needed to allow for more definitive conclusions regarding the role of 
obesity in neurologic recovery.  
 This study found that IML length and Cervical Kyphosis were excellent radiological 
predictors of ΔmJOA in patients on admission. These results are similar to a study on thoracic 
myelopathy which found IML to be a predictor of postoperative outcomes.[16] However kyphosis 
was not a parameter studied in this paper. This may suggest IML may be a better prognosticating 
factor for postoperative recovery. A potential counseling and research assessment tool is 
described in Tables 4 and 5. Through entering the patient’s BMI, Cervical Kyphosis extent, and 
IML, the scale will have the potential to prognosticate recovery following surgical 
decompression in patients with CSM.  Therefore, further research with larger patient samples 
will be needed to more reliably assess the potential differences in predictive ability between 
prognosticating factors in order to generate an accurate prognosticating index. 
Conclusions 
 This study showed that clinical and radiological parameters can be measured to assess 
improvement following surgical decompression using ΔmJOA within a consecutive single 
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surgeon CSM patient sample. Further, BMI, Cervical Kyphosis, and IML can predict improved 
postoperative outcomes (ΔmJOA) assessed more than one year later. Interestingly, 
intermedullary lesion length (IML) may be a better prognosticating factor. Further studies should 
ideally apply a larger sample size to better assess prognosticating factors to derive a more 
accurate prognosticating index. The predictive ability of these measures can be applied to better 
counsel patients and improve stratification in interventional studies.  
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Table 1. Univariate analysis of demographic and clinical factors  
 
No sig 
ΔmJOA 
Sig ΔmJOA P 
Value 
N 18 32  
Age (mean, yrs.) 64.33 ± 
10.79 
63.53 ± 9.93 0.792 
Sex   0.264 
     Male  13 (72.2%) 18 (56.3%)  
     Female 5 (27.8%) 14 (43.8%)  
BMI 28.07 ± 7.84 32.66 ± 6.20 0.027 
Smoking status   0.689 
     Never Smoker 6 (33.3%) 13 (40.6%)  
     Former Smoker 9 (50.0%) 12 (37.5%)  
     Current Smoker 3 (16.7%) 7 (21.9%)  
Type II DM 5 (27.8%) 7 (21.9%) 0.639 
CAD 3 (16.7%) 7 (21.9%) 0.730 
HTN 11 (61.1%) 21 (65.6%) 0.750 
COPD/PulmHTN 4 (22.2%) 5 (15.6%) 0.705 
CHF 1 (5.6%)  3 (9.4%) ≥0.99 
Duration of symptoms 21.39 ± 
27.27 
37.13 ± 
64.89 
0.435 
Hx Neck Surgery 3 (16.7%)  5 (15.6%) ≥ 0.99 
Data presented as mean ± SD or n (%).  
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Table 2. Univariate analysis of radiographic factors 
 
No sig 
ΔmJOA 
Sig ΔmJOA P 
Value 
Cervical Kyphosis 6 (33.3%) 1 (3.1%) 0.006 
No CSF Ant and Pst 1.72 ± 1.13 0.91 ± 0.78 0.010 
No CSF Ant or Pst 0.94 ± 0.80 1.09 ± 0.86 0.490 
Overall Compressed Levels 2.67 ± 1.19 2.00 ± 1.11 0.038 
T2 Signal Change (y/n) 15 (83.3%) 11 (34.4%) 0.001 
Number of Levels with T2 Signal Change 1.28 ± 1.02 0.34 ± 0.48 <0.001 
Intramedullary Lesion Length (mm) 12.57 ± 9.84 2.78 ± 4.43 <0.001 
T1 Signal Change 3 (16.7%) 2 (6.3%) 0.336 
MRI AP Canal Diameter (most severe; mm) 5.18 ± 1.18 6.69 ± 1.76 0.003 
Spinal Cord (most severe; mm) 3.86 ± 1.06 4.96 ± 1.11 0.001 
Torg Pavlov Ratio Average 0.65 ± 0.12 0.77 ± 0.14 0.007 
Lateral Mass Canal Diameter Ratio Average 0.69 ± 0.06 0.71 ± 0.05 0.385 
Pre-op mJOA 12.39 ± 1.82 12.34 ± 2.10 0.939 
Pre-op Nurick 3.28 ± 0.90 2.59 ± 0.98 0.014 
Follow-up 1420.9 ± 
791.77 
1345.4 ± 
698.6 
0.571 
Data presented as mean ± SD or n (%).  
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Table 3. Multivariate Analysis of risk factors associated with ΔmJOA.  
Variable Coefficient (B) Odds Ratio 95% CI p Value 
BMI 0.129 1.138 1.001-1.293 0.048 
Cervical Kyphosis -2.164 0.115 0.009-1.412 0.091 
IML 0.195 0.823 0.715-0.946 0.006 
Constant -1.778 0.169  0.351 
Variables included in model at step one:  
 
 
 
 
 
 
 
 
  
 24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 Point system for the prediction of  ΔmJOA 
Risk Factor Categories Points 
#1   
  0 
  1 
  3 
  4 
  6 
  7 
#2   
  0 
  5 
#3   
  0 
  6 
#4   
  0 
  7 
#5   
  0 
  1 
  2 
  3 
  4 
  7 
 
Table 5 Predicted likelihood of mJOA improvement 
Point Total Risk Point Total Risk Point Total Risk 
0  11  22  
1  12  23  
2  13  24  
3  14  25  
4  15  26  
5  16  27  
6  17  28  
7  18  29  
8  19  30  
9  20  31  
10  21  32  
 
